Cash · 2011–2025
Teva Pharmaceutical Industries cash
$3.6B+7.8% · FY2025
Teva Pharmaceutical Industries (TEVA) reported $3.6B in cash for fiscal 2025, +7.8% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $3.6B | +7.8% | Open → |
| FY20242024-12-31 | $3.3B | +2.3% | Open → |
| FY20232023-12-31 | $3.2B | +15.2% | Open → |
| FY20222022-12-31 | $2.8B | +29.4% | Open → |
| FY20212021-12-31 | $2.2B | −0.6% | Open → |
| FY20202020-12-31 | $2.2B | +10.2% | Open → |
| FY20192019-12-31 | $2.0B | +10.8% | Open → |
| FY20182018-12-31 | $1.8B | +85.0% | Open → |
| FY20172017-12-31 | $963M | −2.5% | Open → |
| FY20162016-12-31 | $988M | −85.8% | Open → |
| FY20152015-12-31 | $6.9B | +212.0% | Open → |
| FY20142014-12-31 | $2.2B | +114.5% | Open → |
| FY20132013-12-31 | $1.0B | −63.9% | Open → |
| FY20122012-12-31 | $2.9B | +162.7% | Open → |
| FY20112011-12-31 | $1.1B | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +8.8%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Teva Pharmaceutical Industries cash |url=https://companiesranked.com/en/company/teva-pharmaceutical-industries/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Teva Pharmaceutical Industries cash. CompaniesRanked. https://companiesranked.com/en/company/teva-pharmaceutical-industries/cash-on-handBibTeX
@misc{companiesranked-en-company-teva-pharmaceutical-industries-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Teva Pharmaceutical Industries cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/teva-pharmaceutical-industries/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-323619 · July 29, 2026
{{cite web |title=Teva Pharmaceutical Industries cash — 10-Q (0001193125-26-323619) |url=https://www.sec.gov/Archives/edgar/data/818686/000119312526323619/d118828d10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.